Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
378.1 USD | -0.81% | -0.36% | +6.71% |
04:47pm | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
03:01pm | Everest Medicines Commercially Launches Kidney Disease Drug in China | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.71% | 16.57B | |
+19.09% | 64.61B | |
+4.95% | 30.63B | |
+13.59% | 11.83B | |
+9.09% | 2.13B | |
+7.69% | 1.79B | |
+8.32% | 1.01B | |
+41.13% | 651M | |
-17.79% | 597M | |
+13.84% | 460M |
- Stock Market
- Equities
- EG Stock
- News Everest Group, Ltd.
- Wells Fargo Adjusts Price Target on Everest Group to $461 From $452, Maintains Overweight Rating